Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN

Molecular and Cellular Biology

Volumn 20, Issue 23, 2000, Pages 8969-8982

  Nakamura, N ^a   Ramaswamy, S ^a   Vazquez, F ^a   Signoretti, S ^a   Loda, M ^a   Sellers, W R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

BIOLOGICAL TRANSPORT; CELL COMPARTMENTATION; CELL CYCLE; CELL CYCLE PROTEINS; CELL DEATH; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HALF-LIFE; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034462121     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.23.8969-8982.2000     Document Type: Article

References (75)

1. The akt kinase: Molecular determinants of oncogenicity
2. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
3. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
4. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
5. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
6. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
7. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
8. Regulation of cell death protease caspase-9 by phosphorylation
9. Antiapoptotic signaling in LNCaP prostate cancer cells: A survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B
10. High-efficiency transformation of mammalian cells by plasmid DNA
11. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
12. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
13. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
14. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
15. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
16. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma
17. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
18. Impaired fas response and autoimmunity in Pten(+/-) mice
19. Pten is essential for embryonic development and tumour suppression
20. Real-time quantitative RT-PCR after laser-assisted cell picking
21. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells
22. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
23. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene
24. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway
25. daf-2, daf-16 and daf-23: Genetically interacting genes controlling Dauer formation in Caenorhabditis elegans
26. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma
27. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence
28. A simplified system for generating recombinant adenoviruses
29. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
30. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation
31. Direct control of the Forkhead transcription factor AFX by protein kinase B
32. Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association
33. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
34. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
35. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene
36. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
37. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
38. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas
39. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate
40. KIP1
41. The Akt kinase signals directly to endothelial nitric oxide synthase
42. The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway
43. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function
44. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
45. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
46. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans
47. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway
48. NF-KappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase
49. A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans
50. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor
51. Production of high-titer helper-free retroviruses by transient transfection
52. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
53. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
54. PTEN/ MMAC1 mutations in endometrial cancers
55. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN
56. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas
57. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
58. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma
59. PIK3CA is implicated as an oncogene in ovarian cancer
60. Cyclin E-CDK2 is a regulator of p27Kip1
61. Interleukin 3-dependent survival by the Akt protein kinase
62. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
63. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
64. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-triphosphate and Akt/protein kinase B signaling pathway
65. Inhibition of cell migration, spreading, and focal adhesion by tumor suppressor PTEN
66. Negative regulation of the forkhead transcription factor FKHR by Akt
67. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies
68. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes
69. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
70. Phosphorylation of the PTEN tail regulates protein stability and function
71. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling
72. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
73. Somatic mutations of PTEN in glioblastoma multiforme
74. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
75. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation